Citadel Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-95,780
| Closed | -$1.18M | – | 15990 |
|
|
2024
Q4 | $1.18M | Sell |
95,780
-1,077,709
| -92% | -$12.3M | ﹤0.01% | 6677 |
|
|
2024
Q3 | $13.4M | Buy |
1,173,489
+113,919
| +11% | +$1.14M | ﹤0.01% | 2523 |
|
|
2024
Q2 | $7.57M | Sell |
1,059,570
-615,524
| -37% | -$4.71M | ﹤0.01% | 3170 |
|
|
2024
Q1 | $11.2M | Buy |
1,675,094
+1,390,252
| +488% | +$9.56M | ﹤0.01% | 2801 |
|
|
2023
Q4 | $1.85M | Sell |
284,842
-754,479
| -73% | -$4.86M | ﹤0.01% | 5499 |
|
|
2023
Q3 | $9.81M | Buy |
1,039,321
+926,903
| +825% | +$11.2M | ﹤0.01% | 2710 |
|
|
2023
Q2 | $1.57M | Buy |
112,418
+71,135
| +172% | +$1.21M | ﹤0.01% | 5601 |
|
|
2023
Q1 | $774K | Sell |
41,283
-3,698
| -8% | -$60.7K | ﹤0.01% | 7357 |
|
|
2022
Q4 | $619K | Buy |
44,981
+24,462
| +119% | +$375K | ﹤0.01% | 7799 |
|
|
2022
Q3 | $392K | Buy |
+20,519
| New | +$374K | ﹤0.01% | 8991 |
|
|
2022
Q2 | – | Sell |
-79,170
| Closed | -$1.17M | – | 14343 |
|
|
2022
Q1 | $1.61M | Buy |
79,170
+67,556
| +582% | +$1.38M | ﹤0.01% | 6573 |
|
|
2021
Q4 | $339K | Sell |
11,614
-106,056
| -90% | -$3.03M | ﹤0.01% | 10658 |
|
|
2021
Q3 | $2.54M | Buy |
117,670
+57,033
| +94% | +$1.38M | ﹤0.01% | 5771 |
|
|
2021
Q2 | $1.56M | Sell |
60,637
-76,849
| -56% | -$1.64M | ﹤0.01% | 7234 |
|
|
2021
Q1 | $2.51M | Sell |
137,486
-44,501
| -24% | -$739K | ﹤0.01% | 5871 |
|
|
2020
Q4 | $2.1M | Buy |
181,987
+13,293
| +8% | +$122K | ﹤0.01% | 5263 |
|
|
2020
Q3 | $1.28M | Buy |
168,694
+145,382
| +624% | +$1.1M | ﹤0.01% | 5571 |
|
|
2020
Q2 | $153K | Buy |
23,312
+7,959
| +52% | +$44.4K | ﹤0.01% | 8734 |
|
|
2020
Q1 | $78K | Sell |
15,353
-37,957
| -71% | -$230K | ﹤0.01% | 8805 |
|
|
2019
Q4 | $409K | Buy |
+53,310
| New | +$311K | ﹤0.01% | 7126 |
|
|
2019
Q3 | – | Sell |
-95,279
| Closed | -$533K | – | 9866 |
|
|
2019
Q2 | $533K | Buy |
+95,279
| New | +$393K | ﹤0.01% | 6731 |
|
|
2019
Q1 | – | Sell |
-72,444
| Closed | -$296K | – | 9992 |
|
|
2018
Q4 | $297K | Sell |
72,444
-16,702
| -19% | -$87.1K | ﹤0.01% | 7295 |
|
|
2018
Q3 | $611K | Buy |
89,146
+11,903
| +15% | +$70.6K | ﹤0.01% | 6375 |
|
|
2018
Q2 | $302K | Buy |
77,243
+12,017
| +18% | +$41.7K | ﹤0.01% | 7199 |
|
|
2018
Q1 | $190K | Buy |
+65,226
| New | +$202K | ﹤0.01% | 7394 |
|
|
2017
Q4 | – | Sell |
-32,998
| Closed | -$104K | – | 8531 |
|
|
2017
Q3 | $104K | Sell |
32,998
-18,009
| -35% | -$67.6K | ﹤0.01% | 7016 |
|
|
2017
Q2 | $218K | Buy |
51,007
+21,628
| +74% | +$88.5K | ﹤0.01% | 6431 |
|
|
2017
Q1 | $134K | Buy |
+29,379
| New | +$98.4K | ﹤0.01% | 6742 |
|
|
2016
Q3 | – | Sell |
-4,227
| Closed | -$11.4K | – | 7886 |
|
|
2016
Q2 | $11K | Buy |
4,227
+2,342
| +124% | +$6.53K | ﹤0.01% | 6722 |
|
|
2016
Q1 | $6K | Sell |
1,885
-5,493
| -74% | -$29.4K | ﹤0.01% | 6619 |
|
|
2015
Q4 | $60K | Buy |
7,378
+5,451
| +283% | +$44K | ﹤0.01% | 7160 |
|
|
2015
Q3 | $14K | Buy |
+1,927
| New | +$16.1K | ﹤0.01% | 8356 |
|
|
2015
Q1 | – | Sell |
-492
| Closed | -$4.74K | – | 8923 |
|
|
2014
Q4 | $5K | Sell |
492
-1,592
| -76% | -$16K | ﹤0.01% | 8276 |
|
|
2014
Q3 | $20K | Sell |
2,084
-2,846
| -58% | -$31.9K | ﹤0.01% | 7429 |
|
|
2014
Q2 | $65K | Sell |
4,930
-2,442
| -33% | -$30.8K | ﹤0.01% | 6556 |
|
|
2014
Q1 | $98K | Buy |
7,372
+2,186
| +42% | +$28.8K | ﹤0.01% | 6218 |
|
|
2013
Q4 | $50K | Buy |
+5,186
| New | +$48.8K | ﹤0.01% | 6039 |
|
|
2013
Q3 | – | Sell |
-16,958
| Closed | -$168K | – | 6903 |
|
|
2013
Q2 | $153K | Buy |
+16,958
| New | +$178K | ﹤0.01% | 4889 |
|
Other funds holding CDMO
Citadel Advisors's CDMO Position: Q1 2025 in Review
Citadel Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 95,780 shares — an estimated $1.18M sold.
Citadel Advisors first reported a position in CDMO in Q2 2013 and held it in 38 quarters. The position peaked at $13.4M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Citadel Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Citadel Advisors sold 95,780 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.18M.
- Citadel Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
- Citadel Advisors's Avid Bioservices, Inc. Common Stock position peaked at $13.4M in Q3 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.